[Aspecific chronic enteropathy in childhood studied by analysis of a series of hospital cases].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002908:Chronic Disease; D004205:Cromolyn Sodium / Q000627:therapeutic use; D003968:Diarrhea, Infantile / Q000209:etiology / Q000628:therapy*; D004406:Dysgammaglobulinemia / Q000150:complications; D004761:Enterocolitis, Pseudomembranous / Q000150:complications; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007410:Intestinal Diseases / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D008286:Malabsorption Syndromes; D010272:Parasitic Diseases / Q000150:complications; D011239:Prednisolone / Q000627:therapeutic use; D011504:Protein-Losing Enteropathies
D000900:Anti-Bacterial Agents; D002792:Cholestyramine Resin; D011239:Prednisolone; D004205:Cromolyn Sodium
Considerazioni sull'enteropatia cronica aspecifica dell'infanzia dall'analisi di una casistica ospedaliera.